INTRODUCTION
============

The microtubule cytoskeleton is responsible for vital cellular processes such as cell division, morphogenesis, and differentiation. Microtubules are 25-nm-diameter hollow cylinders composed of a lattice made up of α-β-tubulin heterodimers aligned head-to-tail to form protofilaments ([@B2]). Microtubules are constantly remodeled through alternating growth and shrinkage of their extremities, a behavior known as dynamic instability ([@B50]). In neurons, microtubules serve as tracks for organelle transport and can be found as single polymers or as linear bundles ([@B16]; [@B43]). Populations of stable microtubule bundles are thought to ensure axon consolidation and maintenance. However, several studies have indicated that microtubules within bundles retain some of their dynamic properties, which are crucial to axon outgrowth, guidance, branching, and regeneration ([@B37]; [@B65]). The unique organizations of neuronal microtubules depend on a variety of microtubule-associated proteins (MAPs) that control microtubule assembly, dynamics, severing, and bundling, as well as interaction with organelles.

Tau is a major neuronal MAP involved in the regulation of microtubule bundling and dynamics ([@B68]; [@B14], [@B15]; [@B5]; [@B10]; [@B20]; [@B8]; [@B64]). As tau plays a role in Alzheimer's disease and related dementias, where it aggregates in paired helical filaments (PHFs) in response to modifications such as phosphorylation, truncation, or mutations, it has been extensively studied ([@B39]; [@B27]; [@B46]; [@B25]). How these pathological forms of tau affect cytoskeletal organization remains a subject of debate, but it could involve detachment of tau from microtubules due to aggregation and/or alterations of tau's microtubule-regulating properties ([@B1]; [@B21]).

Tau is an intrinsically disordered protein consisting of an acidic N-terminal projection domain, a microtubule-binding domain (MTBD) including three or four repeated motifs (R1 to R4), and a C-terminal tail ([Figure 1A](#F1){ref-type="fig"}). Alternative splicings of tau produce six isoforms that differ by the length of the projection domain and the number (three or four) of repeats ([@B36]; [@B29]). Tau interacts with microtubules through multiple binding hotspots located in its MTBD. Among them, two conserved hexapeptides, PHF domains ([Figure 1A](#F1){ref-type="fig"}), are important for tau aggregation in Alzheimer's disease. These PHF domains can fold into hairpin-like structures when tau interacts with microtubules to stabilize a unique microtubule-bound conformation ([@B42]). The MTBD also drives the microtubule-stabilizing activity of tau by stimulating microtubule growth and inhibiting microtubule shrinkage ([@B49]; [@B31]; [@B30]; [@B33]; [@B51]). The projection domain of tau has been proposed to trigger microtubule bundling via complete antiparallel dimerization ([@B58]; [@B23]) or transient charge-charge attractions ([@B13]), although other studies suggest that this domain is not required for microtubule bundling ([@B7]; [@B33]). To date, despite extensive study of tau interaction with single microtubules, the mechanisms by which normal and pathological forms of tau organize microtubule networks remain poorly understood.

![The projection domain of tau modulates tau's capacity to bundle microtubules. (A) Schematic representation of 4R-tau and deletion mutants (ΔN- and ΔNΔC-tau). Tau consists of an N-terminal projection domain, a microtubule-binding domain (MTBD), and a C-terminal tail. The projection domain includes the N-terminal part of the protein and the proline-rich domain P1. The MTBD is composed of a proline-rich domain (P2), four repeats (R1 to R4), and one pseudo-repeat (R'). The two conserved hexapeptides PHF6\* and PHF6 are located at the beginning of R2 and R3, respectively. (B) Effects of full-length and truncated tau proteins on frequency of catastrophes (left) and rescues (right) in single and bundled microtubules (see Supplemental Table S1 for detailed values). Microtubules were assembled from 10 µM tubulin in the presence of 100 nM 4R-tau, ΔN-tau or ΔNΔC-tau. \*\**p* \< 0.01 (Kruskal--Wallis analysis of variance \[ANOVA\] followed by a post hoc Dunn's multiple comparison). *p* values were calculated relative to the 4R-tau condition. (C) TIRF microscopy time series of microtubules growing in the presence of 4R-, ΔN-, and ΔNΔC-tau. White and red arrowheads indicate two distinct microtubule bundling events. Time is indicated in min:s. Scale bars, 10 µm. (D) Kymograph example of microtubules growing in the presence of 4R-tau and forming a stable microtubule bundle. Dotted lines represent the growing extremities of microtubules. Horizontal scale bars: 10 µm; vertical scale bars: 3 min. MT, microtubule. (E) Frequency distributions of crossover (gray), touch-and-run (blue), and zippering (black) events as a function of microtubule collision angles in the presence of 4R-, ΔN-, and ΔNΔC-tau. At least 200 collision events were analyzed for each condition. (F) Distribution of collision angles at which microtubules coalign and zipper in the presence of 4R-tau, ΔN-tau, and ΔNΔC-tau. Boxes represent percentiles 25--75, and whiskers extend from the minimum to the maximum values. The horizontal lines inside boxes indicate median values. \*\*\*\**p* \< 0.0001 (Kruskal--Wallis ANOVA followed by post hoc Dunn's multiple comparison; the numbers of angles measured were 240, 106, and 123 for 4R-tau, ΔN-tau, and ΔNΔC-tau, respectively). *p* values are calculated in comparison to the 4R-tau condition.](mbc-29-154-g001){#F1}

In this paper, we describe in vitro self-organization of growing microtubules in the presence of various tau isoforms, fragments, and mutants. Our results show that the ability of tau to promote stable microtubule bundles depends on the two PHF sequences present in tau repeat motifs and is regulated by tau's projection domain. Importantly, site-specific pseudo-phosphorylation of tau differentially modulates its capacity to either bundle or stabilize microtubules, resulting in distinct network organizations: stable single microtubules, stable bundles, or dynamic bundles. We also identify two disease-relevant mutations of tau that abnormally enhance the formation of bundles composed of highly dynamic microtubules. Cryo--electron microscopy observations reveal that tau and its variants induce changes in the microtubule lattice by increasing the protofilament number and generating lattice defects. Overall, our work sheds light on novel molecular mechanisms by which normal and disease-related forms of tau differentially modulate microtubule bundling and dynamics to control microtubule network organizations.

RESULTS
=======

The tau projection domain regulates its capacity to bundle microtubules
-----------------------------------------------------------------------

To investigate how tau affects the assembly and properties of microtubule bundles in vitro, we performed total internal reflection fluorescence (TIRF)--based assays of microtubules nucleated from randomly oriented short seeds in the presence of pure tubulin (10 µM) and tau proteins or fragments (100 nM) ([Figure 1A](#F1){ref-type="fig"}). Collision events between growing microtubules were classified in three categories: 1) cross-over, 2) touch-and-run, and 3) coalignment followed by zippering and bundling (Supplemental Figure S1). To determine the bundling capacity of tau proteins, we analyzed the frequency of each event category for different microtubule collision angles. In parallel, the parameters of microtubule dynamic instability were determined for both single and bundled microtubules.

Compared with tubulin alone, full-length 4R-tau strongly inhibited catastrophes (transition from growth to shrinkage) and promoted rescues (transition from shrinkage to growth). This finding is consistent with 4R-tau's known microtubule-stabilizing activity ([Figure 1B](#F1){ref-type="fig"} and Supplemental Table S1) ([@B54], [@B55]; [@B64]). 4R-tau also induced the formation of bundles that were absent in the control ([Figure 1, C--E](#F1){ref-type="fig"}, and Supplemental Movie S1); it frequently coaligned and zippered microtubules when they met at shallow angles (\<25°) ([Figure 1, E and F](#F1){ref-type="fig"}). At steeper angles, microtubules formed crossovers or very rarely touch-and-run events. Furthermore, tau-induced bundled microtubules displayed dynamic properties similar to those of single microtubules ([Figure 1B](#F1){ref-type="fig"} and Supplemental Table S1), with bundles composed of stably growing microtubules (referred to as stable microtubule bundles; [Figure 1D](#F1){ref-type="fig"}).

###### Movie S1

Tau promotes the formation of persistently elongating microtubule bundles. TIRF movies of microtubules polymerized from seeds (red) and 10 μM tubulin (green) in the absence (left) or in the presence (right) of 0.1 μM 4R-tau. In the control condition, microtubules are highly dynamic and do not form bundles. Microtubule encounters lead to either cross-over (circle) or touch-and-run (box) events. 4R-tau stabilizes microtubules and induces microtubule co-alignment and zippering (white arrowheads). Time is expressed in min:s Scale bar, 10 μm.

Movie S1

To investigate the roles played by the projection domain and the C-terminal tail of tau in microtubule bundling and dynamics, we produced two fragments: one in which the projection domain was deleted (ΔN-tau), and the other deleted for the projection domain and additional flanking regions of the MTBD (proline-rich domain P2 and C-terminal tail, ΔNΔC-tau) ([Figure 1A](#F1){ref-type="fig"}). The two fragments continued to promote microtubule elongation and stabilization ([Figure 1B](#F1){ref-type="fig"} and Supplemental Table S1) and to bundle microtubules ([Figure 1, C and D](#F1){ref-type="fig"}, and Supplemental Movie S2). Compared with 4R-tau, ΔN- and ΔNΔC-tau enhanced the frequency of microtubule bundling per collision angle and extended the range of angles at which microtubule bundling occurred with angles up to 50° and 35°, respectively ([Figure 1E](#F1){ref-type="fig"}). Owing to this effect, the median bundling angle increased significantly from 9° for the full-length 4R-tau to around 14° for the truncated forms ([Figure 1F](#F1){ref-type="fig"}; see also Supplemental Movie S2). These results indicate that ΔN- and ΔNΔC-tau bundle microtubules more efficiently than full-length 4R-tau.

###### Movie S2

The projection domain of tau regulates its microtubule-bundling efficiency. TIRF movies of microtubules polymerized from seeds (red) and 10 μM tubulin (green) in the presence of 0.1 μM 4R-tau (left) or ΔN-tau (right). The white arrowhead indicates microtubules co-aligning at a steep angle (\> 25°) in the presence of ΔN-tau. By contrast, in the presence of 4R-tau, microtubule bundling occurs only at shallow collision angle (\<25°C). Microtubules that collide at steeper angles yield cross-overs (circles). Time is expressed in min:s. Scale bar, 10 μm.

Movie S2

Overall, our data indicate that full-length tau is an active cross-linker promoting the formation of stable microtubule bundles. The repeat motifs in tau MTBD are sufficient to induce microtubule cross-linking, as suggested by earlier studies ([@B63]; [@B7]). We also show that removal of the N-terminal projection domain of tau stimulates its microtubule bundling capacity.

The PHF domains are key elements in the formation of stable microtubule bundles
-------------------------------------------------------------------------------

We next examined whether tau MTBD regulates microtubule bundling in addition to its role in microtubule binding and stabilization ([@B64]; [@B51]). To do this, we produced various tau mutants lacking one or two repeats or both PHF domains, as these domains have recently been found to play a major role in determining the microtubule-bound conformation of tau ([Figure 2A](#F2){ref-type="fig"}) ([@B42]).

![PHF sequences at the beginning of R2 and R3 are required for tau's microtubule-bundling and -stabilizing functions. (A) Schematic representation of 4R-tau and tau proteins lacking one repeat (3R-tau), two repeats (2R-tau), or the PHF domains (ΔPHF12-, ΔPHF6\*-, and ΔPHF6-tau). Domain details are as in [Figure 1A](#F1){ref-type="fig"}. (B) Frequency of crossover (gray), touch-and-run (blue), and zippering (black) events as a function of microtubule collision angles in the presence of the different tau proteins. Microtubules were assembled from 10 µM tubulin in the presence of 100 nM tau proteins. At least 200 collision events were analyzed for each condition. (C) Distribution of collision angles at which microtubules coalign and zipper in the presence of tau proteins. Boxes represent percentiles 25--75, and whiskers extend from the minimum to the maximum values. The horizontal lines inside boxes indicate median values. \**p* \< 0.05, \*\*\**p* \< 0.001 (Kruskal--Wallis ANOVA followed by post hoc Dunn's multiple comparison; the numbers of angles measured were 240, 128, 14, 24, 66, and 137 for 4R-, 3R-, 2R-, ΔPHF12-, ΔPHF6-, and ΔPHF6\*-tau, respectively). *p* values were calculated relative to the 4R-tau condition. (D) Kymograph examples of microtubules growing in the presence of distinct tau proteins (4R-, 3R-, ΔPHF6\*-, and ΔPHF6-tau) producing different microtubule populations. Dotted lines represent the growing extremities of microtubules. White and black asterisks indicate some catastrophe and rescue events, respectively. Horizontal scale bars: 10 µm; vertical scale bars: 3 min. MT, microtubule. (E) Effects of tau proteins on the frequency of catastrophes (left) and rescues (right) for single and bundled microtubules (see SupplementalTable S1 for detailed values). For 2R-tau, dynamical parameters were determined only for single microtubules because microtubule bundles were too scarce. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\*\**p* \< 0.0001, \#\#\#*p* \< 0.001, \#\#\#\#*p* \< 0.0001 (Kruskal--Wallis ANOVA followed by post hoc Dunn's multiple comparison). *p* values were calculated relative to single (\*) or bundled (\#) microtubules polymerized in the presence of 4R-tau.](mbc-29-154-g002){#F2}

We first determined the ability of these tau variants to bind polymerizing microtubules at the same tau:tubulin ratio as the one used in our TIRF-based experiments, using cosedimentation assays as described previously ([@B48]; [@B45]). We showed that all constructs interacted with microtubules to similar extents (Supplemental Figure S2), which supports the implied role of the repeat motifs and their flanking regions in microtubule binding ([@B52]). Because of this result, we are confident that the differences subsequently observed in the microtubule-regulating activities of tau constructs (microtubule bundling and/or stabilization) are due to inherent mechanistic differences and not to variations in their binding stoichiometry to microtubules. In vitro TIRF reconstitution showed that 3R-tau produced microtubule bundles with an efficiency almost comparable to that of 4R-tau, whereas 2R-tau exhibited very weak bundling activity (Supplemental Movie S3). Detailed analysis of bundling angle distributions indicated no major differences between 3R- and 4R-tau, whereas 2R-tau dramatically reduced both the probability of microtubule bundling per collision and the median bundling angle ([Figure 2, B and C](#F2){ref-type="fig"}). Touch-and-run events were observed with 3R-tau and more frequently with 2R-tau ([Figure 2B](#F2){ref-type="fig"}, in blue). This result correlates with the weaker microtubule stabilization (more catastrophes and fewer rescues) exerted by tau containing a reduced number of repeats ([Figure 2E](#F2){ref-type="fig"} and Supplemental Table S1; also see Supplemental Movie S3; [@B64]). Thus 3R-tau produces bundles composed of dynamic microtubules (referred to as dynamic microtubule bundles, [Figure 2D](#F2){ref-type="fig"}), whereas 2R-tau mainly produces single dynamic microtubules. Interestingly, in the presence of a tau mutant lacking the two PHF sequences (ΔPHF12-tau), growing microtubules behaved similarly to microtubules assembled with 2R-tau: they were highly dynamic and underwent very few coalignments, and those only at acute collision angles (\<13°) ([Figure 2, B, C, and E](#F2){ref-type="fig"}, and Supplemental Movie S3).

###### Movie S3

The PHF domains of tau are key determinants for microtubule bundling and stabilization. TIRF movies of microtubules polymerized from seeds (red) and 10 μM tubulin (green) in the presence of 0.1 μM 3R-, 2R- and ΔPHF12-tau. White stars indicate dynamic bundled microtubules with 3R-tau and short lifetime bundles with 2R- and ΔPHF12-tau. Cross-over and touch-and-run events occurring at weak encountering angles with 2R-tau and ΔPHF12-tau are indicated by circles and boxes, respectively. Time is expressed in min:s. Scale bar, 10 μm.

Movie S3

To test whether the highly dynamic behavior of microtubules assembled with 2R- or ΔPHF12-tau might alter the formation of microtubule bundles, we performed experiments at a higher tubulin concentration (17 µM) to ensure the production of longer, less dynamic polymers (Supplemental Figure S3 and Supplemental Movie S4). Under these conditions, a strong reduction of both microtubule bundling frequencies and median values of bundling angles was still observed in the presence of 2R- and ΔPHF-12-tau compared with 4R-tau. These data indicate that the two central repeats or the PHF sequences are essential to tau's capacity to bundle microtubules, and that this role is independent of the dynamic characteristics of microtubules.

###### Movie S4

2R-tau is much less efficient than 4R-tau in bundling microtubules at high tubulin concentration. TIRF movies of microtubules polymerized from seeds (red) and 17 μM tubulin (green) in the presence of 0.03 μM 4R-tau and 2R-tau. White arrowheads indicate stably growing microtubule bundles in the presence of 4R-tau. In the presence of 2R-tau, bundles (white star) mainly forms at encountering angles below 10 degrees. The circle shows one cross-over event occurring at shallow encountering angle. Time is expressed in min:s Scale bar, 10 μm.

Movie S4

We next examined whether the two PHF sequences exhibited a distinct regulating activity in microtubule bundling and stabilization. Deletion of the PHF domain in R2 (ΔPHF6\*-tau, [Figure 2A](#F2){ref-type="fig"}) decreased microtubule stabilization (to a similar extent to that observed with 3R-tau, [Figure 2, D and E](#F2){ref-type="fig"}) but induced no major changes in microtubule bundling from 4R-tau ([Figure 2, B and C](#F2){ref-type="fig"}). In contrast, deletion of the PHF domain in R3 (ΔPHF6-tau, [Figure 2A](#F2){ref-type="fig"}) massively reduced both tau's bundling and stabilizing capacity ([Figure 2, B--E](#F2){ref-type="fig"}, and Supplemental Movie S5). Thus, the two PHF domains are both involved in microtubule stabilization, and the domain located at the beginning of R3 plays a key role in microtubule bundling.

###### Movie S5

The two PHF domains differentially contribute to tau\'s microtubule-bundling activity. TIRF movies of microtubules polymerized from seeds (red) and 10 μM tubulin (green) in the presence of 0.1 μM ΔPHF6\*-tau and ΔPHF6-tau. White stars indicate dynamic bundled microtubules with ΔPHF6\*-tau and short lifetime bundles with ΔPHF6-tau. In presence of ΔPHF6-tau, there are more touch-and-run events (box). Time is expressed in min:s. Scale bar, 10 μm.

Movie S5

Differential tau phosphorylation promotes distinct microtubule organizations
----------------------------------------------------------------------------

Phosphorylation of tau is known to modulate its microtubule-binding and -stabilizing properties ([@B27]; [@B53]). Among the 40 phosphorylation sites identified to date, a few located within tau MTBD have been found to modulate tau's effect on microtubule dynamics, but none have been reported to affect its microtubule bundling function directly ([@B64]; [@B45]). To investigate how phosphorylation of tau affects bundle assembly and behavior, we generated phosphorylation-mimicking glutamate mutants on specific sites located in distinct tau subdomains identified as major regulators of microtubule behavior ([@B27]; [@B53]; and the present work). These sites are phosphorylated under physiological conditions. The mutants produced were S46E/T69E/S113E (distal part of the projection domain), S175E/T181E (proximal part of the projection domain), S262E (first repeat of MTBD), S305E (adjacent to the PHF domain in R3), and S404E (C-terminal tail) ([Figure 3A](#F3){ref-type="fig"}). All these mutants bound microtubules with a similar stoichiometry under self-assembly conditions at tau:tubulin molar ratios comparable to those used in TIRF-based assays (Supplemental Figure S2). Our results show that the S175E/S181E-tau mutant still stabilized microtubules ([Figure 3B](#F3){ref-type="fig"} and Supplemental Table S2) and bundled them as efficiently as the unmodified 4R-tau ([Figure 3, C and D](#F3){ref-type="fig"}). As previously reported ([@B64]; [@B45]; [@B57]), S262E-tau mutant exhibited decreased microtubule-stabilizing activity compared with 4R-tau (more catastrophes, fewer rescues, and appearance of touch-and-run events, [Figure 3, B and C](#F3){ref-type="fig"}, and Supplemental Table S2). However, our results indicate that this mutant could still cross-link microtubules ([Figure 3, C and D](#F3){ref-type="fig"}) to produce dynamic microtubule bundles ([Figure 3E](#F3){ref-type="fig"} and Supplemental Movie S6). In contrast, phosphomimicking mutations in the distal part of the projection domain (S46E/T69E/S113E), in the C-terminal tail (S404E), or in the vicinity of the PHF domain in R3 (S305E) had no significant impact on tau's capacity to stabilize microtubules ([Figure 3B](#F3){ref-type="fig"} and Supplemental Table S2), but they did considerably reduce the frequency of polymer bundling, thus promoting the assembly of networks mostly made of single stable networked microtubules ([Figure 3, C--E](#F3){ref-type="fig"}, and Supplemental Movie S6). Taken together, these results strongly suggest that phosphorylation of tau affects its capacity to either bundle or stabilize microtubules, leading to the formation of distinct microtubule organizations (Supplemental Movie S6).

![Site-specific pseudophosphorylation of tau differentially regulates its ability to bundle and stabilize microtubules. (A) Schematic representation of 4R-tau and the pseudophosphorylated mutants used in this study. In each tau mutant, specific serine or threonine residues were mutated to glutamate to mimic phosphorylation: S46, T69, and S113 in the distal part of the projection domain (46/69/113-tau); S175 and T181 in the proximal part of the projection domain (175/181-tau); S262 (262-tau) and S305 (305-tau) in the first and second repeats of the MTBD, respectively; and S404 in the C-terminal tail (404-tau). Arrows indicate the positions of amino acid substitutions. (B) Effects of tau phosphomutants on the frequency of catastrophes (left) and rescues (right) for single and bundled microtubules (see Supplemental Table S2 for detailed values). Microtubules were assembled from 10 µM tubulin in the presence of 100 nM 4R-tau or the tau phosphomutants. \*\*\**p* \< 0.01, \*\*\*\**p* \< 0.0001, \#\#*p* \< 0.01, \#\#\#*p* \< 0.001, \#\#\#\#*p* \< 0.0001 (Kruskal--Wallis ANOVA followed by post hoc Dunn's multiple comparison). *p* values were calculated relative to single (\*) or bundled (\#) microtubules polymerized in the presence of 4R-tau. (C) Frequency distributions of crossover (gray), touch-and-run (blue), and zippering (black) events as a function of microtubule collision angles in the presence of tau phosphomutants. At least 200 collision events were analyzed for each condition. (D) Distribution of collision angles at which microtubules coalign in the presence of 4R-tau and tau phosphomutants. Boxes represent percentiles 25--75, and the whiskers extend from the minimum to the maximum values. The horizontal lines inside boxes indicate median values. \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001 (Kruskal--Wallis ANOVA followed by post hoc Dunn's multiple comparison; the numbers of angles measured were 236, 207, 81, 110, 123, and 101 for 4R-, 175/181-, 262-, 46/69/113, 305-, and 404-tau, respectively). *p* values were calculated relative to the 4R-tau condition. (E) Kymograph examples of microtubules growing in the presence of three pseudophosphorylated tau forms (175/181-, 262-, and 305-tau) producing different microtubule populations. Dotted lines represent the growing extremities of microtubules. White and black asterisks indicate some catastrophe and rescue events, respectively. Horizontal scale bars: 10 µm; vertical scale bars: 3 min. MT, microtubules.](mbc-29-154-g003){#F3}

###### Movie S6

Tau pseudo-phosphorylation distinctly modifies the ability of tau to bundle or stabilize microtubules. TIRF movies of microtubules polymerized from seeds (red) and 10 μM tubulin (green) in the presence of 0.1 μM S175E/T181E-tau (175/181-tau), S262E-tau (262-tau) and S404E-tau (404-tau). White arrowheads indicate the formation of stable microtubule bundles with 175/181- and 404-tau. In the presence of 404-tau, bundles mainly occur at weak angles. The majority of encountering events yield cross-overs (circle). White stars indicate dynamic microtubules bundles in the presence of 262-tau. Time is expressed in min:s. Scale bar, 10 μm.

Movie S6

Pathological mutations of tau increase the formation of dynamic microtubule bundles
-----------------------------------------------------------------------------------

Mutations in the tau gene have been identified in a particular type of neurodegenerative dementia known as frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) ([@B26]; [@B39]). These mutations either alter tau splicing, modifying the normal 1:1 ratio of 3R- to 4R-tau, or result in amino acid substitutions and deletions that generally impair tau's microtubule-stabilizing effect ([@B3]; [@B9]; [@B48]; [@B21]). To examine how FTDP-17 point mutations influence the ability of tau to organize microtubules, we generated recombinant forms of three different FTDP-17 tau mutants: ΔK280-tau, where the lysine residue located at the end of the PHF sequence in R2 was deleted; P301L-tau, which has a proline-to-leucine substitution in a conserved loop next to the PHF domain in R3 ([@B4]; [@B42]); and V337M, containing a valine-to-methionine substitution in R4 ([Figure 4A](#F4){ref-type="fig"}). Previous studies indicated that these mutants still interact with microtubules but have a compromised ability to regulate their assembly ([@B3]; [@B48]; [@B21]). Under our TIRF-based assay conditions, all three mutants bound microtubules with a stoichiometry similar to that of 4R-tau (Supplemental Table S2). However, while V337M-tau behaved similarly to 4R-tau ([Figure 4, B--D](#F4){ref-type="fig"}), the P301L and ΔK280 mutations altered both microtubule-bundling and -stabilizing properties of tau. These two mutants are poor microtubule stabilizers, and microtubules therefore undergo many catastrophes and very few rescues ([Figure 4B](#F4){ref-type="fig"}). Simultaneously, these mutants increased the formation of microtubule bundles ([Figure 4, C and D](#F4){ref-type="fig"}, and Supplemental Movie S7) by enhancing the probability of bundling per collision and promoting microtubule coalignments at significantly greater angles than with 4R-tau and V337M-tau. This effect was much greater with P301L-tau. This concomitant up-regulation of microtubule bundling and down-regulation of microtubule stability by tau mutants led to the formation of highly dynamic microtubule bundles. These data demonstrate that pathological mutations of tau can alter its ability to bundle and stabilize microtubules in opposing ways.

![FTDP-17 mutant forms of tau exhibit enhanced microtubule bundling activity together with reduced microtubule-stabilizing effect. (A) Schematic representation of FTDP-17 tau mutants used in this study. Point mutations were located at the sites indicated. Domain details are as in [Figure 1A](#F1){ref-type="fig"}. (B) Effects of tau mutants on the frequency of catastrophes (left) and rescues (right) for single and bundled microtubules (see Supplemental Table S3 for detailed values). Microtubules were assembled from 10 µM tubulin in the presence of 100 nM 4R-tau or tau FTDP-17 mutants. \*\*\*\**p* \< 0.0001, \#\#\#\#*p* \< 0.0001 (Kruskal--Wallis ANOVA followed by post hoc Dunn's multiple comparison). *p* values were calculated relative to single (\*) or bundled (\#) microtubules polymerized in the presence of 4R-tau. (C) Frequency distributions for crossover (gray), touch-and-run (blue), and zippering (black) events as a function of microtubule collision angles in the presence of tau FTDP-17 mutants. At least 200 collision events were analyzed for each condition. (D) Distribution of collision angles at which microtubules coalign in the presence of 4R-tau and FTDP17 mutants. Boxes represent percentiles 25--75, and whiskers extend from the minimum to the maximum values. The horizontal lines inside boxes indicate median values. \*\**p* \< 0.01, \*\*\*\**p* \< 0.0001 (Kruskal--Wallis ANOVA followed by post hoc Dunn's multiple comparison; the numbers of angles measured were 235, 166, 145, and 233 for 4R-, V337M-, ΔK280-, and P301L-tau, respectively). *p* values were calculated relative to the 4R-tau condition.](mbc-29-154-g004){#F4}

###### Movie S7

P301L-tau exhibits enhanced MT-bundling activity together with reduced MT-stabilizing effect. TIRF movies of microtubules polymerized from seeds (red) and 10 μM tubulin (green) in the presence of 0.1 μM 4R- and P301L-tau. 4R-tau induces persistently growing microtubule bundles (white arrowhead) whereas P301L-tau promotes the formation of dynamic bundles (white stars). Moreover, microtubules co-alignment in the presence of P301L-tau can occur at significantly steeper angles than in the presence of 4R-tau (white star on the right panel). With 4R-tau, microtubules encountering at angles greater than 25 degrees do not co-align and cross-over (circle). Time is expressed in min:s. Scale bar, 10 μm.

Movie S7

Tau proteins modify the lattice organization of growing microtubules
--------------------------------------------------------------------

The differential effects of tau proteins on microtubule bundling could be explained by tau-induced changes of microtubule structure. Indeed, the ability of microtubules to undergo the bending deformations required for their coalignment and subsequent bundling, depends on their mechanical properties, which are likely influenced by their lattice organization. For instance, an increase in protofilament number would stiffen microtubules ([@B28]; [@B44]), whereas local lattice defects, such as transitions in the number of protofilaments, may make microtubules more flexible ([@B56]; [@B60]). A recent study indicated that tau increases the average radius of prepolymerized taxol-stabilized microtubules ([@B11]), but we still do not know how microtubules copolymerized with tau are organized. To gather information, we performed cryo--electron microscopy on microtubules that had been self-assembled in the presence of 4R-tau or some of the tau constructs described above. The constructs studied in these assays were chosen for their various effects on microtubule bundling. The images showed that, compared with the control population, which was mainly composed of 13-protofilament microtubules, all the tau constructs tested promoted the assembly of microtubules with 14 protofilaments ([Figure 5, A and C](#F5){ref-type="fig"}). Small percentages of 15- and 16-profilament microtubules were also observed under these conditions. In addition, transitions in the number of protofilaments (e.g., from 13--14 protofilaments; double arrows in [Figure 5, A and B](#F5){ref-type="fig"}) were observed along individual microtubules, producing local lattice defects. Such defects could be produced by end-to-end annealing of microtubules over time ([@B59]) or directly generated during the microtubule elongation process ([@B12]; [@B60]). We do not favor the former hypothesis, because end-to-end annealing has been evidenced in mixtures of preformed stable microtubules ([@B59]; [@B17]; [@B32]), which is very different from our cryo--electron microscopy conditions (growing microtubules). The frequency of protofilament transitions was enhanced two- to fourfold in the presence of tau proteins and mutants over the control condition ([Figure 5D](#F5){ref-type="fig"}). Overall, these data suggest that tau and the variants assayed in this study all generate similar lattice modifications during microtubule assembly, characterized by an increase in both protofilament number and protofilament transitions.

![Tau proteins modify the microtubule lattice organization. (A) Cryo--electron microscopy image of microtubules assembled from tubulin in the presence of tau. The protofilament number is indicated below each microtubule and the protofilament transitions are shown by double arrows. Scale bar: 100 nm. (B) Filtered image of the transition from 14 to 13 protofilaments labeled in panel A (i). (C) Effect of tau proteins on the distribution of microtubules depending on their protofilament number (see color code). Microtubules were assembled with either tubulin alone (60 µM) or tubulin (20 µM) and various tau proteins (5 µM). Under these conditions, the initial growth rates determined by spin-down assays (see *Materials and Methods*) were comparable (2.56 ± 0.09, 2.09 ± 0.04, 2.18 ± 0.04, 2.38 ± 0.03, 2.47 ± 0.09, 2.13 ± 0.04, 2.25 ± 0.06, and 2.66 ± 0.04 µm·min^--1^ for tubulin alone, 4R-tau, ΔN-tau, 3R-tau, 262-tau, 305-tau, 404-tau and P301L-tau respectively). (D) Effect of tau proteins on the frequency of protofilament transitions.](mbc-29-154-g005){#F5}

DISCUSSION
==========

In recent years, substantial progress has been made in understanding how tau interacts with microtubules *via* its MTBD ([@B51]; [@B42]). However, the mechanisms by which tau assembles linear microtubule bundles from dynamic polymers remain poorly understood. Using TIRF-based reconstitution assays, we were able to demonstrate that tau is an active bundler that promotes the coalignment and zippering of growing microtubules. Cryo--electron microscopy further revealed that tau changes the structure of microtubules during assembly by increasing the protofilament number and generating lattice defects. These modifications induced by tau might influence microtubule properties. Indeed, an increase in the protofilament number is assumed to stiffen microtubules ([@B28]; [@B44]), which may account for how tau promotes microtubule rigidity ([@B24]; [@B35]). In contrast, lattice defects have been proposed to make microtubules more flexible ([@B40]; [@B60]). How such opposite effects on microtubule mechanical properties could be related to the bundling process is unclear and will require further analysis. Strikingly, all of the tau forms tested in this study induced the same microtubule lattice changes regardless of their microtubule bundling efficiency. This suggests that the bundling efficiency of tau proteins depends on alternative microtubule-­independent regulatory mechanisms related to the intrinsic properties of tau (see below).

Tau's projection domain is described as the main element responsible for microtubule bundling through complete dimerization ([@B58]; [@B23]) or transient charge--charge attractions ([@B13]), while the MTBD is considered to control microtubule dynamics ([@B7]; [@B64]; [@B30]). Surprisingly, our results indicated that a small fragment of tau, restricted to the repeat motifs, is sufficient to bundle microtubules with even stronger efficiency than that of full-length tau, suggesting an alternative bundling mechanism. One possible explanation for this observation is that basic C-terminal tau fragments stimulate microtubule bundling via electrostatic attraction between negatively charged microtubules, as suggested for cationic polyamines and more recently for N-terminally deleted forms of tau ([@B34]; [@B13]). Conversely, as previously suggested ([@B11]), the negative charges in the projection domain could decrease tau bundling efficiency by exerting a repulsive effect on adjacent microtubules. Our data are consistent with previous studies proposing a negative impact of the N-terminal domain of tau on its microtubule-based functions ([@B63]; [@B7]; [@B69]; [@B18]). This strongly suggests that cleavage of tau's projection domain confers a gain of function on the protein. This gain of function might alter cytoskeleton and neuronal integrity in the brains of patients with Alzheimer's disease, where both N- and C-terminally truncated tau fragments have been identified ([@B67]; [@B70]; [@B18]).

Unexpectedly, our results show that the C-terminal MTBD of tau, in addition to its microtubule-stabilizing role, also strongly influences the formation of microtubule bundles. We identified the two conserved PHF sequences located in the second and third repeats of the MTBD as key determinants for this regulation: both PHF sequences contribute to microtubule stabilization, whereas the sequence located in R3 also plays a major role in microtubule bundle assembly ([Figure 6](#F6){ref-type="fig"}). The essential role of the two PHF domains in regulating microtubule dynamics is in line with their involvement in tau folding upon binding to the microtubule ([@B42]) and in promoting microtubule self-assembly ([@B31]). We propose that local changes within (ΔK280-tau) or next to (S262E-tau, P301L-tau) the PHF sequences could modify how the MTBD interacts with microtubules, thereby altering tau's ability to stabilize microtubules while still bound to them (Supplemental Figure S2). These types of local perturbation of the MTBD conformation have recently been highlighted upon tau MTBD pseudophosphorylation ([@B62]). Furthermore, the PHF domain located in R3 plays a specific, and essential, role in microtubule coalignment, as shown by the facts that its deletion inhibits microtubule bundling, and that mutations located next to this domain (P301L, S305E) have a strong impact on microtubule bundling. If we assume that the microtubule-bundling mechanism involves complete dimerization ([@B58]; [@B23]) or charge-charge attractions ([@B13]) of the tau projection domain, our data suggest that the PHF sequence in R3 influences these interaction processes by modifying the overall conformation of the N-terminal part of tau. In line with this hypothesis, intramolecular contacts have been identified between the PHF sequence in R3 and the projection domain in soluble tau ([@B51]). Moreover, a very recent study proposed that microtubule-bound tau molecules in cells display a paperclip conformation with the N- and C-termini folding back onto the MTBD, which also supports a relationship between the MTBD and the projection domain of the tau molecule ([@B19]).

![Tau switches microtubule network organizations depending on its physiological or pathological states. (A) Main tau subdomains involved in regulating microtubule bundling and dynamics. The projection domain is involved in microtubule bundling, whereas the two PHF domains influence both microtubule dynamics and bundling. (B) Schematic representation of the distinct microtubule organizations promoted by tau depending on its physiological or pathological modifications. (C) Microtubule bundling vs. stabilizing properties of tau proteins. The ability of tau proteins to bundle microtubules is estimated based on mean bundling angle; their ability to stabilize microtubules corresponds to the mean frequency of catastrophes. MTs, microtubules.](mbc-29-154-g006){#F6}

Interestingly, phosphorylation and disease-related mutations of tau promoted distinct microtubule organizations by differentially regulating microtubule bundling or stabilization ([Figure 6](#F6){ref-type="fig"}). Mutations that impair tau-mediated microtubule stabilization were restricted to the MTBD (S262E-tau, ΔK280, P301L); those affecting tau-mediated microtubule bundling were located in various tau subdomains (projection domain, MTBD, and C-terminal tail). As suggested above, such site-dependent effects may involve modifications of how tau MTBD interacts with microtubules and/or how tau folds onto the microtubule surface. Consistently, tau pseudophosphorylation was reported to induce conformational changes of soluble tau, characterized by swinging movements of tau's projection domain and/or C-terminal tail ([@B41]). Mutations and phosphorylation within or next to tau MTBD have also been recently proposed to alter the global hairpin conformation of microtubule-bound tau molecules in cells ([@B19]). These changes could affect tau--tau interaction and subsequent microtubule bundling. Overall, these results have important implications for the normal and pathological functions of tau. First, they strongly suggest that tau's capacity to distinctly regulate its microtubule-bundling and -stabilizing activities can be tightly controlled by its phosphorylation state and/or alternative splicing (4R vs. 3R). This newly identified balancing mechanism, illustrated in [Figure 6](#F6){ref-type="fig"}, is essential for tau to generate distinct microtubule organizations, which might play key roles in a number of microtubule-dependent neuronal functions such as axonal elongation, internal trafficking and maintenance ([@B43]; [@B65]). Second, our results provide further insights into how pathological tau modifications, such as disease-related increased phosphorylation levels or mutations, might alter microtubule organization by promoting the formation of specific networks (e.g., stable single microtubules or highly dynamic bundles). One prevailing view is that tau-related diseases are linked to detachment of tau from microtubules, leading to microtubule destabilization ([@B46]). Our results appear to indicate an alternative situation where pathological forms of tau continue to bind to microtubules but misregulate their dynamic and/or bundling properties.

In conclusion, our results reveal novel mechanisms by which tau is able to switch microtubule network organization via the differential regulation of microtubule bundling and dynamics. We further provide evidence that nonphysiological modifications of tau can compromise one or both of these activities, leading to loss of function (reduced microtubule stability or bundling) and/or gain of function (increased microtubule bundling) effects. Taken together, these data strongly suggest an active role for nonaggregated pathological forms of tau in altering cytoskeleton properties. Our findings support the view that pathways other than tau aggregation and detachment from microtubules are involved in the progression of neurodegenerative diseases ([@B46]; [@B47]) and might open up new perspectives on the development of novel therapeutic strategies.

MATERIALS AND METHODS
=====================

DNA constructs and reagents
---------------------------

Human tau isoforms containing one insert (N) and either three or four repeats (R) (3R- and 4R-tau, respectively) were used in this study. The following tau constructs were generated by a PCR-based strategy (amino acid numbering is given according to the longest 2N4R-tau isoforms): ∆N-tau and ∆N∆C-tau, corresponding to aa 198--441 and 244--400, respectively; 2R-tau, corresponding to the deletion of R2 and R3 (aa 275--336); ∆PHF6\*-tau, ∆PHF6-tau and ∆PHF12-tau in which aa 275--280, 306--311, and both PHF sequences were deleted. Tau phosphomutants were generated by PCR using the QuickChange II XL site-directed mutagenesis kit (Agilent Technologies) to exchange serine or threonine for glutamic acid residues. A similar approach was used to produce FTDP17 mutants of tau. Most constructs were subcloned in the pDEST17 (Invitrogen) vector, except ∆N-tau and ∆N∆C-tau, which were subcloned in the pET-28a vector (Novagen).

Protein purification
--------------------

His-tagged recombinant tau proteins were expressed in *Escherichia coli* strain BL21-DE3-pLysS (constructs cloned in pET-28a) or BL21-AI (constructs cloned in pDEST17) (Invitrogen). Expression of ΔN- and ΔN∆C-tau fragments was induced by adding 1 mM IPTG to the culture medium and incubating for 3 h at 37°C. Expression of the other tau forms was induced by overnight incubation with 0.2% [l]{.smallcaps}-arabinose at 18°C. Soluble proteins were extracted from cells in lysis buffer (40 mM Tris-HCl, 500 mM NaCl, protease inhibitor cocktail \[Roche\], pH 7.0) by three freeze/thaw cycles and sonication. Clarified lysates were mixed with Talon metal affinity resin (Clontech) for 1 h at 4°C in Buffer A (20 mM Tris-HCl, 500 mM NaCl, 10 mM imidazole, 0.1% Triton, pH 7.0). The resin was washed three times in buffer A before proteins were eluted with buffer A supplemented with 200 mM imidazole. Samples were further processed by size-exclusion chromatography in BRB80 buffer (80 mM Pipes, 1 mM EGTA, 1 mM MgCl~2~, pH 6.74). Purified proteins were concentrated and frozen in liquid nitrogen. Protein concentrations were determined by a Bradford assay using bovine serum albumin (BSA) as a standard.

Tubulin was purified from fresh bovine brain and fluorescently labeled with ATTO 488 and ATTO 565 (ATTO-TEC GmbH, Germany) or biotinylated according to [@B38].

TIRF microscopy
---------------

Microtubule seeds were obtained by polymerizing 10 µM tubulin (50% biotinylated tubulin and 50% ATTO 565--labeled tubulin) in the presence of 1 mM guanosine-5′-\[(α,β)-methyleno\]triphosphate (GMPCPP) in BRB80 at 35°C for 1 h. Microtubule seeds were then centrifuged for 5 min at 68,000 × *g*, resuspended in an equal volume of BRB80 supplemented with 1 mM GMPCPP, and stored in liquid nitrogen until needed.

Perfusion chambers were prepared with functionalized silane-PEG-biotin (Laysan Bio) coverslips and silane-PEG (Creative PEGworks) glass slides, as described previously ([@B56]; [@B22]) The flow cell was successively perfused with neutravidin (25 µg/ml in 1% BSA in BRB80) (Pierce), PLL-g-PEG (2 kD, 0.1 mg/ml in 10 mM HEPES, pH 7.4) (Jenkem), BSA (1% in BRB80 buffer), and microtubule seeds. Microtubule assembly was initiated from the seeds attached to the coverslip surface by injecting 10 µM tubulin (containing 30% ATTO 488--labeled tubulin) in the presence of 100 nM of the different tau proteins in TIRF assay buffer (4 mM dithiothreitol, 1% BSA, 50 mM KCl, 1 mg/ml glucose, 70 µg/ml catalase, 580 µg/ml glucose oxidase, 0.017% methylcellulose (1500 centipoise) in BRB80). Dual-color time-lapse images were recorded using an inverted Eclipse Ti microscope (Nikon) with an Apochromat 60 × 1.49 numerical aperture oil immersion objective (Nikon), equipped with an iLas^2^ TIRF system (Roper Scientific) and a cooled charge-coupled device camera (EMCCD Evolve 512, Photometrics) controlled by MetaMorph 7.7.5 software (Molecular Devices). Fluorescence was excited using 491-and 561-nm lasers, and time-lapse imaging was performed at a rate of one frame per 5 s with an 80-ms exposure time for 45--60 min.

Microtubule bundling and dynamics analysis
------------------------------------------

Image analysis was performed using ImageJ ([@B61]). Microtubule dynamic parameters were determined on kymographs using an in-house KymoTool macro. Growth and shrinkage rates were calculated from the slopes of the microtubule growth and shrinkage phases. The catastrophe and rescue frequencies were determined by dividing the number of events per microtubule by the time spent in growing and shrinking states, respectively. The contact angles between microtubules upon collision were measured on the movie frames for each outcome (crossover, zippering, and touch-and-run). Event frequencies were calculated for 10° contact angle windows from 0° to 90°.

Measuring microtubule growth rate in self-assembly conditions used for cryo--electron microscopy experiments
------------------------------------------------------------------------------------------------------------

Because microtubule growth rate has been proposed to influence the formation of lattice defects ([@B12]; [@B40]; [@B60]), cryo--electron microscopy conditions were set up to get similar initial growth rates in the absence (control conditions) and in the presence of tau proteins. Microtubules were self-assembled from 60 µM tubulin (10% ATTO 488--labeled tubulin and 90% unlabeled tubulin) or 20 µM tubulin in the presence of 5 µM 4R-tau proteins in BRB80--50 mM KCL buffer supplemented with 1 mM GTP. Tubulin assembly was initiated at 35°C and assembly was stopped after 2 min by adding 1 ml of BRB80 containing 0.5% glutaraldehyde and 25% (wt/vol) sucrose. Microtubules were then centrifuged on coverslips for 20 min at 68,000 × *g* at 25°C before being fixed in ice-cold methanol (10 min at --20°C) and washed in PBS-Tween 0.1%. Microtubules were observed under an epifluorescence microscope. Using ImageJ software, the lengths of at least 100 microtubules were measured on each coverslip. Mean growth rates were determined from mean microtubule length measurements.

Cryo--electron microscopy
-------------------------

Vitreous-ice-embedded microtubules were prepared under a controlled atmosphere with constant temperature/humidity using the vitrification robot Vitrobot MARK IV (FEI). Microtubules were polymerized for at least 10 min at 35°C from 60 µM tubulin alone or a mix of 20 µM tubulin and 5 µM 4R-tau proteins. Samples (4 µl) were dropped onto holey carbon grids within the warm and humid chamber of the Vitrobot, blotted, and plunged into liquid ethane. Specimens were observed under low-dose conditions using a transmission electron microscope (FEI Tecnai F20 200 kV FEG) equipped with an FEI eagle 4K CCD camera.

Printed images were analyzed to determine microtubule lattice organization based on the specific moiré fringe pattern resulting from the two-dimensional projection of protofilaments ([@B66]). Microtubules with 13 unskewed protofilaments display a continuous contrast image, whereas all other configurations produce images characterized by alternating fringe patterns that vary according to the protofilament number. Microtubule lengths were measured using an electronic ruler (Silva); these lengths then served to determine the proportions of the different microtubule populations. A total length of at least 300 µm was measured under each condition. Filtered images of microtubules were generated in ImageJ using Tubule J software provided by Denis Chrétien ([@B6]).

Statistics
----------

All statistical analyses were performed using Prism 6 (GraphPad Software, USA).
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